Unknown

Dataset Information

0

Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.


ABSTRACT: The protein 14-3-3sigma is involved in the regulation of cellular processes such as apoptosis, cell cycle progression and proliferation. Disruption of protein expression has been implicated in a number of malignancies. Here we examine the expression pattern of 14-3-3sigma in breast cancer and specifically consider whether expression in ductal carcinoma in situ (DCIS) lesions is predictive of disease outcome. We examined 14-3-3sigma protein expression and localization using immunohistochemical staining on a high-density tissue microarray consisting of 157 invasive breast cancer patients. Statistical analyses were used to assess the correlation of 14-3-3sigma expression with clinico-pathological parameters and patient outcome. We observed a statistically significant increase in 14-3-3sigma protein expression in ductal hyperplasia, DCIS, and invasive ductal carcinoma (IDC) as compared normal glandular epithelium. In IDC, lower expression of 14-3-3sigma tended to predicted poorer survival time while in DCIS lesions, there was a stronger correlation between relatively higher levels of 14-3-3sigma predicting shorter survival time. Further, of patients who had concurrent DCIS and IDC lesions, those that exhibited a decrease of 14-3-3sigma expression from DCIS to IDC had significantly shorter survival time. Our findings indicate that 14-3-3sigma expression may be a useful prognostic indicator for survival in patients with breast cancer with an elevated 14-3-3sigma in earlier disease predicting a less favorable disease outcome. To our knowledge this is the first published study associating 14-3-3sigma protein expression with breast cancer survival.

SUBMITTER: Yoon NK 

PROVIDER: S-EPMC3170666 | biostudies-literature | 2009

REPOSITORIES: biostudies-literature

altmetric image

Publications

Higher expression levels of 14-3-3sigma in ductal carcinoma in situ of the breast predict poorer outcome.

Yoon Nam K NK   Seligson David B DB   Chia David D   Elshimali Yahya Y   Sulur Giri G   Li Ai A   Horvath Steve S   Maresh Erin E   Mah Vei V   Bose Shikha S   Bonavida Benjamin B   Goodglick Lee L  

Cancer biomarkers : section A of Disease markers 20090101 4


The protein 14-3-3sigma is involved in the regulation of cellular processes such as apoptosis, cell cycle progression and proliferation. Disruption of protein expression has been implicated in a number of malignancies. Here we examine the expression pattern of 14-3-3sigma in breast cancer and specifically consider whether expression in ductal carcinoma in situ (DCIS) lesions is predictive of disease outcome. We examined 14-3-3sigma protein expression and localization using immunohistochemical st  ...[more]

Similar Datasets

| S-EPMC6447831 | biostudies-other
| S-EPMC5008774 | biostudies-literature
| S-EPMC3893342 | biostudies-literature
| S-EPMC7777562 | biostudies-literature
| S-EPMC4362647 | biostudies-other
2007-07-27 | GSE8591 | GEO
| S-EPMC4608608 | biostudies-literature
| S-EPMC4480702 | biostudies-literature
| S-EPMC4746086 | biostudies-other
| S-EPMC6664779 | biostudies-literature